Finance

Lists
033270:KRX
KOREA UNITED PHARM INC
၁၇,၄၅၀.၀၀ ₩
-၁.၉၇%
(-၃၅၀.၀၀) 1D
အောက် ၂၀, GMT+၉ ၁၂:၄၄:၅၅  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 033270...
Open
၁၇,၇၀၀ ₩
High
၁၇,၈၇၀ ₩
Low
၁၇,၄၁၀ ₩
Mkt. cap
ဋေ ၂.၇၈ သ
Avg. vol.
၂.၈၉ သောင်း
Volume
၁.၉၆ သောင်း
Dividend
၃.၅၀%
Quarterly dividend
၁၅၂ ₩
Ex-dividend date
၂၀၂၃ ဒီ ၂၇
P/E ratio
၃.၅၄
52-wk high
၂၁,၈၀၀ ₩
52-wk low
၁၆,၁၀၀ ₩
EPS
၄,၉၂၅ ₩
Shares outstanding
၁.၅၉ ကုဋေ
No. of employees
၉၁၈
Open
၁၇,၇၀၀ ₩
High
၁၇,၈၇၀ ₩
Low
၁၇,၄၁၀ ₩
Mkt. cap
ဋေ ၂.၇၈ သ
Avg. vol.
၂.၈၉ သောင်း
Volume
၁.၉၆ သောင်း
Dividend
၃.၅၀%
Quarterly dividend
၁၅၂ ₩
Ex-dividend date
၂၀၂၃ ဒီ ၂၇
P/E ratio
၃.၅၄
52-wk high
၂၁,၈၀၀ ₩
52-wk low
၁၆,၁၀၀ ₩
EPS
၄,၉၂၅ ₩
Shares outstanding
၁.၅၉ ကုဋေ
No. of employees
၉၁၈
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၄၈ မိနစ်
Sam Stovall says history is key to what happens to the S&P 500 next year
Kalkine Media
Kalkine Media
·
ပြီးခဲ့သည့် ၁ နာရီ
Can AI-Driven Dash Search Keep Dropbox (NASDAQ:DBX) in Focus?
CNBC
CNBC
·
ပြီးခဲ့သည့် ၂ နာရီ
CNBC Daily Open: Tech investors buy the dip — but debt remains a concern
About KOREA UNITED PHARM INC
CEOWon-Ho Kang | Kang Duk-young
Employees၉၁၈
Founded၁၉၈၇
Headquarters-
Sector-
Websitekup.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more
Google အက်ပ်များ